Page 1 Nyrada Inc. Level 22/23, Salesforce Tower, 180 George Street, Sydney NSW 2000 ARBN 625 401 818 25 September 2026 Sydney, Australia Cleansing Statement Nyrada Inc (ASX:NYR), a clinical-stage biotechnology company focused on developing Transient Receptor Potential Canonical (TRPC) ion...
Cleansing Statement
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nyrada
- Application for quotation of securities - NYR
- Proposed issue of securities - NYR
- Cap Raise Deck-Building the Future of TRPC-based Therapies
- Nyrada Successfully Raises AU$12.0 Million Via Placement
- Trading Halt
Later from Nyrada
- Nyrada US Patent for Xolatryp Granted
- 2026 AGM Letter to Shareholders, Notice of Meeting & Proxy
- Securities Purchase Plan Offer Booklet
- Attaching Options Prospectus
- Nyrada Receives Positive FDA Feedback
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada